MED AD NEWS April 2001

MOST RECOGNIZED PAIN AND INFLAMMATION BRANDS

Naming Consultants

2,000 physicians and pharmacists from North America and Europe were surveyed by Brand Institute Inc., a biotechnology branding, pharmaceutical branding, and consumer branding consultancy firm, to determine the most-recognizable pharmaceutical name brands in the pain and inflammation category. According to results from Brand Institute’s Brandpoll.com, the most recognized pain and inflammation drug to North American health-care professionals is Motrin (ibuprofen). Motrin is an over-the-counter drug that is indicated for the temporary relief of headache, muscular aches, the minor pains of arthritis, toothache, backache, minor aches and pains associated with the common cold, the pains of menstrual cramps, and for reduction of fever. The product is marketed in the United States by McNeil Consumer Healthcare, a subsidiary of Johnson & Johnson.

In Europe, the most-recognized brand for pain and inflammation among health-care professionals is Voltaren (diclofenac). The product is indicated for the acute and chronic treatment of signs and symptoms of osteoarthritis and the acute and chronic treatment of signs and symptoms of rheumatoid arthritis. Voltaren is marketed by Novartis Pharma AG (www.novartis.com). The product generated sales of $801.6 million in 2000.
Naming Consultants